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Pathophysiology of Ovarian Cancer
Christina M. Eagle BSN RN
Otterbein University, Westerville, Ohio

Case Study

Signs & Symptoms

A 20-year-old female presented to her gynecologist complaining of abdominal pain, pelvic pain,
and pain in the small of her back, which had begun to worsen. She also felt bloated and was
having frequent problems with indigestion and gas. In addition, she was tired all the time and
rarely went to the gym anymore.

•

Her medical history showed her to be a healthy and athletic female. She admitted to drinking
occasionally at social events but denied having ever smoked. She had been receiving annual
gynecological exams since she was 18 years old, and her menstrual history has been
unremarkable. Her family history showed that her mother was a breast and ovarian cancer
survivor. The patient was not on birth control medication, but she stated that she practices
safe sex with the use of condoms.

•

The gynecologist performed a pelvic examination of the patient’s vagina, uterus, rectum and
pelvis, including ovaries, and checked for masses or growths. He followed the pelvic exam with
a transvaginal ultrasound to better detect the presence of abnormal growths in the
reproductive organs. The transvaginal ultrasound revealed a mass on her right ovary (PRIME
Education, 1997-2019).

•

Introduction
•

•

•

Worldwide, approximately 240,000
women are diagnosed with ovarian
cancer each year, and 140,200 were
projected to succumb to this disease
in 2016.

Ovarian cancer is difficult to detect, especially in the
early stages (National Ovarian Cancer Coalition). This is
partly due to the fact that the ovaries – two small,
almond-shaped organs on either side of the uterus – are
deep within the abdominal cavity (NOCC). The following
are often identified by women as some of the signs and
symptoms of ovarian cancer:
• Bloating
• Pelvic or abdominal pain
• Trouble eating or feeling full quickly
• Feeling the need to urinate urgently or often (NOCC).
Other symptoms of ovarian cancer can include:
• Fatigue
• Upset stomach or heartburn
• Back pain
• Pain during sex
• Constipation or menstrual changes (NOCC).
When the symptoms are persistent, when they do not
resolve with normal interventions (like diet change,
exercise, laxatives, rest) it is imperative for a woman to
see her doctor (NOCC). Persistence of symptoms is key
(NOCC).

•

•

•

•

•
•
•

•

This case-to-fatality ratio is nearly
three times that of breast cancer,
making ovarian cancer the most
lethal gynecological malignancy in
developed countries.
Patients with stage III or IV disease
have a dismal 25% 5-year survival
rate (Kroeger, Jr. & Drapkin, 2017).

The majority of ovarian cancers are of epithelial
origin, whereas fewer ovarian cancers develop from the
remaining cell types, such as sex-cord stromal, germ cell,
or mixed cell-type tumors.
The most common histological subtypes of epithelial
ovarian carcinomas are serous (68-71%), endometrioid
(9-11%), clear cell (12-13%), mucinous (3%), transitional
(1%), and mixed histologies (6%).
Several groups have now convincingly established that
there are 2 distinct types of epithelial ovarian carcinoma:
type I and type II.
Type I tumors arise via well-recognized sequence either
from borderline serous tumors or from endometriosis
and include low-grade serous carcinoma, endometrioid,
and clear-cell carcinoma.
These tumors are often early stage and low-grade tumors,
with a relatively indolent disease course.
Type II carcinomas are more frequent, usually of serous
histology, are high grade, and seem to originate from the
fimbrial epithelium in up to 60% of the cases.
Subsequently, high-grade serous carcinomas present
clinically as stage 3 or 4 disease, consistent with the
hypothesis of peritoneal seeding by malignant cells from
the fimbriated end of the tubes.
At the time of diagnosis, the majority of epithelial ovarian
cancers are advanced-stage, high-grade serous
carcinomas and have a poor prognosis compared with
early-stage carcinomas (Nezhar, Apostal, Nezhat &
Pajovic, 2015).

Significance of Pathophysiology
•

Clinical observations and the new recent evidence for the
pathogenesis of ovarian cancer have set ground for
implementing new strategies for screening and
prevention programs to reduce the incidence of
epithelial ovarian cancer .

•

Until specific markers are developed, able to detect
different histological epithelial cancers, it is reasonable
to monitor women for risk factors and pursue riskreducing medical and surgical treatment options to
reduce the risk of these types of cancers (Nezhar,
Apostal, Nezhat & Pajovic, 2015).
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Oncology became a way of life in 2002 with the diagnosis of this author’s 4-year-old
daughter with metastatic Ewing’s Sarcoma, a form of bone or soft tissue cancer. During
this life journey, this author made the decision to pursue an education in nursing. After
the passing of said daughter in 2003, everything oncology-related became this nurse’s
passion. For the past seven years this nurse has practiced in radiation oncology with the
hope and desire to be more of an advocate to those battling a cancer-related diagnosis as
an advanced practice nurse.
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Implications for
Nursing Care

Underlying Pathophysiology

Becoming familiar with and
educating women about risk
factors and the elusive
symptoms of ovarian cancer
can increase patient autonomy
and advocacy, as well as
potentially improve patient
outcomes for those affected by
ovarian cancer (Stewart,
Ralyea & Lockwood, 2019).

Conclusion
•

•

•

•

There is no screening test
for ovarian cancer and
with diagnosis often in
the late stages, recurrence
is high in this population.
Early identification can
range from knowing the
vague symptoms
associated with the
cancer to prophylactic
surgical removal of atrisk tissue.
Standard treatment for
ovarian cancer is surgery
followed by combination
chemotherapy.
Although advances are
being made, ovarian
cancer remains the most
fatal female gynecologic
cancer (Stewart, Ralyea &
Lockwood, 2019).
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